Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Withdrawn before enrolling · Phase 1

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Key facts

Study ID

NCT00000199

Run by

University of Pennsylvania

People needed

0

Last updated by the study team

2017-03-30

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.